At some point in their commercialization pathway, young medtech and life science companies – or even individuals – need to activate strategies and execute action items to build awareness for and uptake of their new technologies. The solution providers on which they rely (like GCMI) also need to keep their new business or projects pipeline healthy as well.
The connection? Many times those marketing and biz dev responsibilities fall to medtech experts, not marketing experts. How, then, can scientists make the most of their precious time when marketing and biz dev responsibilities are well outside of their area of expertise?
On September 29th, GCMI Director of Scientific Affairs Evan Goldberg and Jackson Medical COO Kamil Makhnejia joined Write2Market VP, Healthcare Paul Snyder, to unpack it all.
A few key takeaways:
- Build trust with your scientific peers, then get them what they need.
- Examine and start to execute on positioning, audiences, marketing plan and sales at the point of design freeze optimally, manufacturing transfer at the latest.
- Tie your sales and marketing messaging back to the voice of the customer.
- Closely examine the competition including the conferences in which they invest at the same time.
- Buyers and decision makers are often not the same in the healthcare market. Each will need customized messages (think the different types of people in value analysis teams)
If you’d like to send Paul a specific question, email paul@write2market.com. In the meantime, we hope you find the recording informative.